Literature DB >> 25437972

Patient-reported outcomes of electrodessication and curettage for treatment of nonmelanoma skin cancer.

Elyse Galles1, Rupa Parvataneni2, Sarah E Stuart2, Eleni Linos2, Sungat Grewal3, Mary-Margaret Chren4.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25437972      PMCID： PMC4251522          DOI： 10.1016/j.jaad.2014.06.038

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  4 in total

1.  Recurrence rates of treated basal cell carcinomas. Part 2: Curettage-electrodesiccation.

Authors:  M K Silverman; A W Kopf; C M Grin; R S Bart; M J Levenstein
Journal:  J Dermatol Surg Oncol       Date:  1991-09

2.  Quality-of-life outcomes of treatments for cutaneous basal cell carcinoma and squamous cell carcinoma.

Authors:  Mary-Margaret Chren; Anju P Sahay; Daniel S Bertenthal; Saunak Sen; C Seth Landefeld
Journal:  J Invest Dermatol       Date:  2007-02-15       Impact factor: 8.551

3.  Patient satisfaction after treatment of nonmelanoma skin cancer.

Authors:  Maryam M Asgari; Daniel Bertenthal; Saunak Sen; Anju Sahay; Mary-Margaret Chren
Journal:  Dermatol Surg       Date:  2009-05-08       Impact factor: 3.398

4.  Tumor recurrence 5 years after treatment of cutaneous basal cell carcinoma and squamous cell carcinoma.

Authors:  Mary-Margaret Chren; Eleni Linos; Jeanette S Torres; Sarah E Stuart; Rupa Parvataneni; W John Boscardin
Journal:  J Invest Dermatol       Date:  2012-11-29       Impact factor: 8.551
  4 in total
  2 in total

Review 1.  Management of keratinocyte carcinoma - Special considerations in the elderly.

Authors:  Alison Bailey; Brooke Vasicek; Joy Tao; Monica Janeczek; Andia Mitri; Rebecca Tung
Journal:  Int J Womens Dermatol       Date:  2019-05-18

Review 2.  Advances in Management and Therapeutics of Cutaneous Basal Cell Carcinoma.

Authors:  Olivia M Chen; Keemberly Kim; Chelsea Steele; Kelly M Wilmas; Nader Aboul-Fettouh; Carrick Burns; Hung Quoc Doan; Sirunya Silapunt; Michael R Migden
Journal:  Cancers (Basel)       Date:  2022-07-30       Impact factor: 6.575
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.